Pfizer Inc said it has won a patent challenge by generic drug manufacturer Synthon Pharmaceuticals over the active ingredient in its hypertension drug Norvasc. The company said a federal court in the Middle District of North Carolina upheld the company's US patent covering amlodipine besylate. The decision, which is subject to appeal, prohibits Synthon from launching a generic version of amlodipine until September 2007.

Posted by GEN-ERIC at 02:25:54 am into the following categories: In The News

---

http://gen-eric.com/patents/htsrv/trackback.php/831

Name:

Email: (not displayed on this site)

Site/Url:

Comment text:

Allowed XHTML tags: <p, ul, ol, li, dl, dt, dd, address, blockquote, ins, del, a, span, bdo, br, em, strong, dfn, code, samp, kdb, var, cite, abbr, acronym, q, sub, sup, tt, i, b, big, small>

URLs, email, AIM and ICQs will be converted automatically.

Options:
Auto-BR (Line breaks become <br />)
Remember me (Set cookies for name, email & url)